Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience.
Studies have addressed cost-effectiveness of syphilis testing of pregnant women in high-prevalence settings. This study compares costs of rapid syphilis testing (RST) with laboratory-based rapid plasma reagin (RPR) tests in low-prevalence settings in Peru. The RST was introduced in a tertiary-level...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2016-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4780822?pdf=render |
| _version_ | 1818846200809390080 |
|---|---|
| author | Patricia Mallma Patricia Garcia Cesar Carcamo Sergio Torres-Rueda Rosanna Peeling David Mabey Fern Terris-Prestholt |
| author_facet | Patricia Mallma Patricia Garcia Cesar Carcamo Sergio Torres-Rueda Rosanna Peeling David Mabey Fern Terris-Prestholt |
| author_sort | Patricia Mallma |
| collection | DOAJ |
| description | Studies have addressed cost-effectiveness of syphilis testing of pregnant women in high-prevalence settings. This study compares costs of rapid syphilis testing (RST) with laboratory-based rapid plasma reagin (RPR) tests in low-prevalence settings in Peru. The RST was introduced in a tertiary-level maternity hospital and in the Ventanilla Network of primary health centers, where syphilis prevalence is approximately 1%. The costs per woman tested and treated with RST at the hospital were $2.70 and $369 respectively compared with $3.60 and $740 for RPR. For the Ventanilla Network the costs per woman tested and treated with RST were $3.19 and $295 respectively compared with $5.55 and $1454 for RPR. The cost per DALY averted using RST was $46 vs. $109 for RPR. RST showed lower costs compared to the WHO standard costs per DALY ($64). Findings suggest syphilis screening with RST is cost-effective in low-prevalence settings. |
| first_indexed | 2024-12-19T05:41:47Z |
| format | Article |
| id | doaj.art-c71e2e912d654560a402bf825862b82e |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-19T05:41:47Z |
| publishDate | 2016-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-c71e2e912d654560a402bf825862b82e2022-12-21T20:33:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01113e014956810.1371/journal.pone.0149568Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience.Patricia MallmaPatricia GarciaCesar CarcamoSergio Torres-RuedaRosanna PeelingDavid MabeyFern Terris-PrestholtStudies have addressed cost-effectiveness of syphilis testing of pregnant women in high-prevalence settings. This study compares costs of rapid syphilis testing (RST) with laboratory-based rapid plasma reagin (RPR) tests in low-prevalence settings in Peru. The RST was introduced in a tertiary-level maternity hospital and in the Ventanilla Network of primary health centers, where syphilis prevalence is approximately 1%. The costs per woman tested and treated with RST at the hospital were $2.70 and $369 respectively compared with $3.60 and $740 for RPR. For the Ventanilla Network the costs per woman tested and treated with RST were $3.19 and $295 respectively compared with $5.55 and $1454 for RPR. The cost per DALY averted using RST was $46 vs. $109 for RPR. RST showed lower costs compared to the WHO standard costs per DALY ($64). Findings suggest syphilis screening with RST is cost-effective in low-prevalence settings.http://europepmc.org/articles/PMC4780822?pdf=render |
| spellingShingle | Patricia Mallma Patricia Garcia Cesar Carcamo Sergio Torres-Rueda Rosanna Peeling David Mabey Fern Terris-Prestholt Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience. PLoS ONE |
| title | Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience. |
| title_full | Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience. |
| title_fullStr | Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience. |
| title_full_unstemmed | Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience. |
| title_short | Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience. |
| title_sort | rapid syphilis testing is cost effective even in low prevalence settings the cisne peru experience |
| url | http://europepmc.org/articles/PMC4780822?pdf=render |
| work_keys_str_mv | AT patriciamallma rapidsyphilistestingiscosteffectiveeveninlowprevalencesettingsthecisneperuexperience AT patriciagarcia rapidsyphilistestingiscosteffectiveeveninlowprevalencesettingsthecisneperuexperience AT cesarcarcamo rapidsyphilistestingiscosteffectiveeveninlowprevalencesettingsthecisneperuexperience AT sergiotorresrueda rapidsyphilistestingiscosteffectiveeveninlowprevalencesettingsthecisneperuexperience AT rosannapeeling rapidsyphilistestingiscosteffectiveeveninlowprevalencesettingsthecisneperuexperience AT davidmabey rapidsyphilistestingiscosteffectiveeveninlowprevalencesettingsthecisneperuexperience AT fernterrisprestholt rapidsyphilistestingiscosteffectiveeveninlowprevalencesettingsthecisneperuexperience |